Creating a whole new market and getting CMS, Medicare, and Medicaid to issue reimbursement codes isn’t easy. In fact, you’d have to be a little crazy to try. Crazy or brilliant.
3X entrepreneur Larry Jasinski definitely isn’t crazy. He knew his company ReWalk was on to something big - and had the data to prove it.
From humble beginnings at Boston Scientific to international entrepreneur, Larry knows his stuff - and is opening up to our listeners and viewers on this week’s episode!
If you’re struggling to break into the market or commercialize your product, you really need to listen to what Larry has to say.
In this episode, he shares the story on how he commercialized his product overseas, brought it to the US, and then compiled the data to support the issuance of a reimbursement code.
Amazed? We were too! So get ready for some insights and tips that just might help you weather the commercialization process along the way!
Here are the show highlights:
- What it’s like to create a whole new market (1:11)
- The biggest limiter to bringing disruptive or incremental innovation to market (3:56)
- From idea to commercially viable - which path do you take? (5:31)
- The current perspective on the investment community (8:03)
- What innovators should do when pitching investors (10:09)
- How to approach commercializing a product internationally (15:06)
- Why having cross-discipline exposure can be key to success (22:27)
I've spoken with dozens of health innovators, and nearly everyone is trying to figure out their best pivot strategy. But they don't know what to change, how to pivot, or if their new pivot strategy is the right move.
So I went into overdrive putting together a clear, actionable 5-step worksheet that will help you quickly define your most viable and profitable pivot path through the COVID crisis. And I’m giving it to you for FREE — no strings attached at legacy-dna.com/pivot
Larry Jasinski is CEO of ReWalk Robotics, a company that produces structural exoskeletons that give paralyzed people the ability to walk again.
From his beginnings at Boston Scientific, Larry attributes cross-disciplinary experience to his successful ventures across the globe - from Germany to Israel to the United States.
Larry earned his BS and MBA from Providence College, University of Bridgeport.